Seguir
David Miklos
David Miklos
Dirección de correo verificada de stanford.edu
Título
Citado por
Citado por
Año
Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma
SS Neelapu, FL Locke, NL Bartlett, LJ Lekakis, DB Miklos, CA Jacobson, ...
New England Journal of Medicine 377 (26), 2531-2544, 2017
46762017
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
FL Locke, A Ghobadi, CA Jacobson, DB Miklos, LJ Lekakis, OO Oluwole, ...
The lancet oncology 20 (1), 31-42, 2019
18312019
KTE-X19 CAR T-cell therapy in relapsed or refractory mantle-cell lymphoma
M Wang, J Munoz, A Goy, FL Locke, CA Jacobson, BT Hill, ...
New England journal of medicine 382 (14), 1331-1342, 2020
13192020
B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies
DA Winer, S Winer, L Shen, PP Wadia, J Yantha, G Paltser, H Tsui, P Wu, ...
Nature medicine 17 (5), 610-617, 2011
11502011
Axicabtagene ciloleucel as second-line therapy for large B-cell lymphoma
FL Locke, DB Miklos, CA Jacobson, MA Perales, MJ Kersten, OO Oluwole, ...
New England Journal of Medicine 386 (7), 640-654, 2022
7442022
Standard-of-care axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma: results from the US Lymphoma CAR T Consortium
LJ Nastoupil, MD Jain, L Feng, JY Spiegel, A Ghobadi, Y Lin, S Dahiya, ...
Journal of Clinical Oncology 38 (27), 3119, 2020
5732020
Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing
SD Boyd, EL Marshall, JD Merker, JM Maniar, LN Zhang, B Sahaf, ...
Science translational medicine 1 (12), 12ra23-12ra23, 2009
5732009
Rituximab for steroid-refractory chronic graft-versus-host disease
C Cutler, D Miklos, HT Kim, N Treister, SB Woo, D Bienfang, LB Klickstein, ...
Blood 108 (2), 756-762, 2006
5112006
Antibody responses to HY minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission
DB Miklos, HT Kim, KH Miller, L Guo, E Zorn, SJ Lee, EP Hochberg, ...
Blood 105 (7), 2973-2978, 2005
4822005
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
D Miklos, CS Cutler, M Arora, EK Waller, M Jagasia, I Pusic, ME Flowers, ...
Blood, The Journal of the American Society of Hematology 130 (21), 2243-2250, 2017
4302017
The biology of chronic graft-versus-host disease: a task force report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in …
KR Cooke, L Luznik, S Sarantopoulos, FT Hakim, M Jagasia, DH Fowler, ...
Biology of Blood and Marrow Transplantation 23 (2), 211-234, 2017
4222017
Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements
SD Boyd, BA Gaëta, KJ Jackson, AZ Fire, EL Marshall, JD Merker, ...
The Journal of Immunology 184 (12), 6986-6992, 2010
3482010
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing
DM Kurtz, MR Green, SV Bratman, F Scherer, CL Liu, CA Kunder, ...
Blood, The Journal of the American Society of Hematology 125 (24), 3679-3687, 2015
3382015
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
JY Spiegel, S Patel, L Muffly, NM Hossain, J Oak, JH Baird, MJ Frank, ...
Nature medicine 27 (8), 1419-1431, 2021
3272021
Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma
FL Locke, JM Rossi, SS Neelapu, CA Jacobson, DB Miklos, A Ghobadi, ...
Blood advances 4 (19), 4898-4911, 2020
2672020
High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment
AC Logan, H Gao, C Wang, B Sahaf, CD Jones, EL Marshall, I Buño, ...
Proceedings of the National Academy of Sciences 108 (52), 21194-21199, 2011
2392011
Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation
JH Antin, HT Kim, C Cutler, VT Ho, SJ Lee, DB Miklos, EP Hochberg, ...
Blood 102 (5), 1601-1605, 2003
2162003
Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation
E Zorn, DB Miklos, BH Floyd, A Mattes-Ritz, L Guo, RJ Soiffer, JH Antin, ...
The Journal of experimental medicine 199 (8), 1133-1142, 2004
2062004
TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated …
HE Kohrt, BB Turnbull, K Heydari, JA Shizuru, GG Laport, DB Miklos, ...
Blood, The Journal of the American Society of Hematology 114 (5), 1099-1109, 2009
1892009
Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus …
KR Schultz, DB Miklos, D Fowler, K Cooke, J Shizuru, E Zorn, E Holler, ...
Biology of Blood and Marrow Transplantation 12 (2), 126-137, 2006
1862006
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20